Sanofi

OTC: SNYNF · Real-Time Price · USD
101.05
2.93 (2.99%)
At close: Aug 15, 2025, 2:18 PM

Sanofi Income Statement

Financials in EUR. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
44.29B 46.44B 45.39B 39.17B
Cost of Revenue
13.21B 14.24B 13.7B 12.26B
Gross Profit
31.08B 32.21B 31.69B 26.92B
Operating Income
14.45B 7.88B 8.5B 8.13B
Interest Income
413M 19M 206M 40M
Pretax Income
6.76B 7.15B 8.27B 7.8B
Net Income
5.56B 5.4B 8.37B 6.22B
Selling & General & Admin
9.18B 10.77B 10.49B 9.55B
Research & Development
7.39B 6.73B 6.71B 5.69B
Other Expenses
7.25B 6.84B -370M -5M
Operating Expenses
23.83B 24.33B 19.81B 17.77B
Interest Expense
749M 710M 440M 368M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
37.03B 38.57B 33.51B 30.03B
Income Tax Expense
1.2B 1.6B 1.5B 1.56B
Shares Outstanding (Basic)
1.25B 1.26B 1.25B 1.25B
Shares Outstanding (Diluted)
1.26B 1.26B 1.26B 1.26B
EPS (Basic)
4.45 4.30 6.69 4.97
EPS (Diluted)
4.43 4.30 6.66 4.95
EBITDA
11.03B 11.39B 13.77B 11.54B
EBIT
7.45B 7.81B 10.88B 8.19B
Depreciation & Amortization
3.59B 4.43B 3.7B 3.13B